KALA BIO, Inc. (KALA) vs Moleculin Biotech, Inc. (MBRX)

KALA BIO, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. KALA BIO, Inc. and Moleculin Biotech, Inc. are of similar size ($11.2M and $10.7M). KALA BIO, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.1×. Across the 9 metrics below, KALA BIO, Inc. leads on 5 and Moleculin Biotech, Inc. on 4.

Valuation

Metric KALA MBRX Biotechnology median
P/E n/m 0.05 7.88
P/S 0.01 n/m 11.47
P/B 0.00 0.29 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.11 0.74
EV/Sales 7.52 n/m 10.73
Earnings yield (6,658.33%) 1,870.40% (28.84%)
Free cash flow yield (56,050.65%) (746.71%) (23.03%)

Profitability

Metric KALA MBRX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (345.32%) (1,471.05%) (57.72%)
Return on assets (43.23%) (152.41%) (49.22%)
Return on invested capital (722.69%) (417.27%) 0.00%

Growth

Metric KALA MBRX Biotechnology median
Revenue growth (TTM) (50.54%) — 5.64%
EPS growth (last fiscal year) 67.39% 82.01% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric KALA MBRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.88 0.94 4.73
Net debt to EBITDA 0.19 0.35 0.96

Dividend

Metric KALA MBRX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric KALA MBRX Biotechnology median
Market cap 10.73m 11.17m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack